Shinya Yamanaka.
Level 5 - mechanism / opinion, no new human data
Expert interview and historical perspective with no primary empirical data (Level 5).
PubMed 41895285 · doi:10.1016/j.xcrm.2026.102719
What was done
An interview conducted by the editorial team of Cell Reports Medicine with Dr. Shinya Yamanaka, reviewing twenty years of progress in induced pluripotent stem cell (iPSC) biology, translational medicine, and clinical applications.
What was found
The abstract reports no quantitative measurements or experimental data. It summarizes discussion topics including historical milestones in regenerative medicine, the utility of iPSCs for disease modeling and drug discovery, synergy with genome editing, current bottlenecks impeding widespread clinical implementation of iPSC-derived therapies, and emerging applications.
Why it matters
Provides an authoritative expert perspective from the pioneer of iPSC technology on the progress, clinical translation challenges, and future therapeutic trajectory of stem cell medicine.
Limits
This is an interview and qualitative commentary without novel empirical, preclinical, or clinical trial data. It does not provide systematic reviews or quantitative analyses.
Cited by
- supports Shinya Yamanaka won the Nobel Prize for discovering how to reprogram mature specialized cells back into pluripotent stem cells.